These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 26680940)

  • 21. A retrospective comparison of concurrent 5-fluorouracil or oral UFT in postoperative chemoradiation for gastric adenocarcinoma.
    Yoney A; Bati Y; Akboru H; Isikli L; Unsal M
    Cancer Radiother; 2010 Jan; 14(1):19-23. PubMed ID: 19963423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma.
    Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cancer; 2005 Jun; 103(11):2338-43. PubMed ID: 15825161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UFT in the treatment of colorectal and breast cancer.
    Sun W; Haller D
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):49-56. PubMed ID: 11219978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorin.
    Peer CJ; McManus TJ; Hurwitz HI; Petros WP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():32-7. PubMed ID: 22565063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of pharmacokinetics of 5-FU and alpha-fluoro-beta-alanine, a metabolite of 5-FU, in plasma after administration of UFT, tegafur, 5-FU or doxifluridine to rats].
    Kuwata K; Nagayama S; Hirakawa Y; Matsushima E; Kawaguchi Y
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):885-90. PubMed ID: 10897216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
    Muggia FM; Wu X; Spicer D; Groshen S; Jeffers S; Leichman CG; Leichman L; Chan KK
    Clin Cancer Res; 1996 Sep; 2(9):1461-7. PubMed ID: 9816321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
    Sekiguchi I; Suzuki M; Tamada T; Nishida M
    Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
    Hortobagyi GN; Young RR; Karwal M; Ibrahim NK; Hermann R; Murray JL; Watkins SP; Gore I
    Cancer; 2010 May; 116(10):2301-6. PubMed ID: 20225231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
    González Barón M; Espinosa E; Feliu J; Ordóñez A; Zamora P; de Castro J; García Girón C; García Alfonso P; Garrido P; Belón J; Lomas M
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):109-12. PubMed ID: 9348581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
    Suenaga M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.
    Bin Q; Li J; Liao C; Cao Y; Gao F
    Colorectal Dis; 2011 Aug; 13(8):837-45. PubMed ID: 20050863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.
    Chen JS; Rau KM; Chen YY; Huang JS; Yang TS; Lin YC; Liau CT; Lee KD; Su YC; Kao RH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):819-25. PubMed ID: 18663448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor efficacy of combination chemotherapy with UFT and cyclophosphamide against human breast cancer xenografts in nude mice.
    Haga S; Shimizu T; Imamura H; Watanabe O; Kinoshita J; Fukushima M; Kajiwara T
    Anticancer Res; 1999; 19(3A):1791-6. PubMed ID: 10470117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
    Hong KD; Lee SI; Moon HY
    Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of additional chemotherapy with oral UFT in intravenous combination chemotherapy with cisplatin and 5-fluorouracil for human gastric cancer xenograft lines of well- and poorly- differentiated adenocarcinomas transplanted in nude mice.
    Tseng CC; Nio Y; Tsubono M; Kawabata K; Masai Y; Hayashi H; Fukumoto M; Tobe T
    Anticancer Res; 1992; 12(4):1295-9. PubMed ID: 1503424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [UFT concentration in various tissues from cancer patients].
    Kasai Y; Nakanishi Y; Nishi H; Nishindai H; Yoshimoto M; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2130-8. PubMed ID: 6414381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT].
    Sinmyo K; Hosoi H; Suwa H; Kitagawa M; Yamaguchi K; Susaki H
    Gan To Kagaku Ryoho; 1989 May; 16(5):2051-7. PubMed ID: 2499267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale for phase I study of UFT plus leucovorin and oral JM-216.
    DeMario MD; Ratain MJ
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):26-9. PubMed ID: 9348563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.